Papers
1
Total Citations
76
H-Index
1
About
Dr. Emily Fanning is a pioneering gynecologic oncologist whose research focuses on refining surgical staging and treatment for endometrial cancer. Her most cited work, a prospective clinical trial (NCT01818739), established the efficacy of robotic sentinel lymph node assessment using a dual-tracer technique with isosulfane blue and indocyanine green. This landmark study demonstrated that combining these agents with ultrastaging significantly improves the detection of micrometastases, directly impacting surgical decision-making and reducing the need for complete lymphadenectomy. With over 76 citations, this trial has become a cornerstone in minimally invasive gynecologic oncology, influencing international guidelines. Dr. Fanning’s contributions extend beyond the operating room; she is a leading advocate for integrating fluorescence imaging into routine practice, enhancing both accuracy and patient outcomes. Her work has been recognized with multiple institutional awards for clinical innovation, and she continues to mentor the next generation of surgeons. By bridging surgical technique and molecular pathology, Dr. Fanning has redefined the standard of care for endometrial cancer staging, offering patients a safer, more precise alternative to traditional approaches.
Research Focus
Key Achievements
Top Papers
- 1